查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1701297

連續生物加工市場規模、佔有率、趨勢分析報告：按產品、應用、最終用途、地區、細分市場預測，2025-2030 年

Continuous Bioprocessing Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables & Reagents), By Application (Monoclonal Antibodies, Vaccines), By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

持續生物加工市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球連續生物加工市場規模預計到2030年將達到9.1143億美元，2025年至2030年期間的複合年成長率為18.63%。

持續生物加工市場受到對生技藥品、生物相似藥、細胞和基因療法以及單株抗體（mAb）等先進療法日益成長的需求的推動。隨著製藥和生技公司尋求更高的效率、更低的成本和更快的生產週期，連續生物加工正在成為關鍵的解決方案。與傳統的批量處理相比，連續生物處理具有更高的生產率、更大的擴充性和改進的製程控制，使其成為大規模生技藥品生產的必需品。此外，一次性生物反應器、基於灌注的系統和製程分析技術 (PAT) 的進步正在加速各行業採用連續生物加工。

由於對快速疫苗生產、可擴展製造和高效供應鏈的需求日益成長，COVID-19 疫情成為採用連續生物加工的主要催化劑。開發 mRNA 疫苗、單株抗體和抗病毒療法的公司已轉向連續生物加工以滿足全球需求，同時維持較高的產品品質。此次疫情也凸顯了傳統批次製程的脆弱性，導致對靈活、擴充性和自動化的連續生物製造解決方案的投資增加。因此，疫情過後，許多生物製藥公司將繼續投資連續生物加工技術，以確保全球生物製造業的長期市場成長和彈性。

生物製藥公司、CMO 和監管機構之間日益加強的合作也在推動市場成長。 FDA 和 EMA 等監管機構正在透過提供指導方針、獎勵和更快的核准途徑積極支持向連續生產的轉變。此外，主要企業正在大力投資自動化、人工智慧主導的流程監控和即時分析，以進一步最佳化製造工作流程。連續層析法、線上品管和模組化生物反應器系統的整合簡化了生技藥品的生產，減少了差異性並確保了產品品質的一致性。

連續生物加工市場報告重點

  • 按產品分類，消耗品和試劑將在 2024 年佔據市場主導地位。從傳統批量處理到連續生物處理的轉變推動了對連續生物處理的消耗品和試劑的需求不斷成長。
  • 根據應用，單株抗體部分將佔據市場主導地位，到 2024 年將佔據 29.98% 的最大收入佔有率。隨著製造商尋求降低生產成本，同時保持高產品純度和效力，向生物學名藥的轉變和對製程強化的監管支持將進一步推動採用。
  • 根據最終用途，製藥和生物技術公司將主導市場，到 2024 年將佔據最大的收益佔有率，達到 48.43%。 FDA 和 EMA 等機構對持續製造和製程改進的監管支持進一步鼓勵生物製藥公司投資下一代生物製程解決方案。
  • 2024年，北美將引領市場，佔據最大的收益佔有率，為37.46%。這一優勢源於對生物製藥研發的大量投資、完善的製造基礎設施以及支持先進生物加工技術的優惠監管政策。

目錄

第1章調查方法與範圍

第2章執行摘要

3. 連續生物加工市場變數與趨勢

  • 市場展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 驅動程式
    • 限制因素
  • 產業分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • COVID-19影響分析

第4章 連續生物加工：產品估算與趨勢分析

  • 產品細分儀表板
  • 連續生物加工市場：產品變異性分析
  • 連續生物加工市場規模與趨勢分析（按產品）（2018-2030）
  • 裝置
    • 2018年至2030年設備市場估計與預測
    • 生物反應器
    • 過濾系統
    • 層析法系統
    • 過程分析技術
    • 其他
  • 耗材和試劑
    • 2018年至2030年消耗品和試劑市場估計和預測
    • 培養基和緩衝液
    • 過濾器和薄膜
    • 樹脂
    • 管和袋
    • 其他

第5章連續生物加工：應用評估與趨勢分析

  • 應用程式細分儀表板
  • 連續生物加工市場：應用趨勢分析
  • 連續生物加工市場規模及應用趨勢分析（2018-2030）
  • 單株抗體
  • 疫苗
  • 細胞和基因治療
  • 研究與開發
  • 其他用途

第6章連續生物加工：最終用途估算與趨勢分析

  • 最終用途細分儀表板
  • 連續生物加工市場：最終用途差異分析
  • 連續生物加工市場規模和趨勢分析（按最終用途）（2018-2030 年）
  • 製藥和生物技術公司
  • CMO和CRO
  • 研究和學術機構

第7章連續生物加工：區域估計與趨勢分析

  • 區域市場儀表板
  • 2024 年及 2030 年區域市場佔有率分析
  • 各地區連續生物加工市場：關鍵要點
  • 北美洲
    • 2018-2030年北美市場估計與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018-2030年歐洲市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 2018-2030年亞太市場估計與預測
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 2018-2030年拉丁美洲市場估計與預測
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 2018-2030年中東和非洲市場估計和預測
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第8章競爭格局

  • 參與企業分類
  • 2024年企業市場分析
  • 參與企業概況
    • Danaher
    • Sartorius AG
    • Thermo Fisher Scientific Inc.
    • WuXi Biologics
    • Ginkgo Bioworks
    • Merck KGaA
    • GE Healthcare
    • Repligen Corporation
    • Asahi Kasei Bioprocess America, Inc.
Product Code: GVR-4-68040-535-2

Continuous Bioprocessing Market Growth & Trends:

The global continuous bioprocessing market size is anticipated to reach USD 911.43 million by 2030, growing at a CAGR of 18.63% from 2025 to 2030, according to a new report by Grand View Research, Inc. The continuous bioprocessing market is driven by the increasing demand for biologics, biosimilars, and advanced therapies such as cell and gene therapies and monoclonal antibodies (mAbs). As pharmaceutical and biotechnology companies seek higher efficiency, reduced costs, and faster production cycles, continuous bioprocessing has emerged as a key solution. Compared to traditional batch processing, continuous bioprocessing offers higher productivity, better scalability, and improved process control, making it essential for large-scale biologics manufacturing. Additionally, advancements in single-use bioreactors, perfusion-based systems, and process analytical technologies (PAT) are accelerating the adoption of continuous bioprocessing across the industry.

The COVID-19 pandemic acted as a major catalyst for the adoption of continuous bioprocessing, as the need for rapid vaccine production, scalable manufacturing, and efficient supply chains intensified. Companies developing mRNA vaccines, monoclonal antibodies, and antiviral therapies turned to continuous bioprocessing to meet global demand while maintaining high product quality. The pandemic also highlighted vulnerabilities in traditional batch processing, leading to increased investments in flexible, scalable, and automated continuous biomanufacturing solutions. As a result, post-pandemic, many biopharma companies have continued to invest in continuous bioprocessing technologies, ensuring long-term market growth and resilience in global biomanufacturing.

The increasing collaboration between biopharma companies, CMOs, and regulatory agencies is also driving market growth. Regulatory bodies such as the FDA and EMA have been actively supporting the shift towards continuous manufacturing by providing guidelines, incentives, and faster approval pathways. Moreover, key players are investing heavily in automation, AI-driven process monitoring, and real-time analytics, further optimizing production workflows. The integration of continuous chromatography, inline quality control, and modular bioreactor systems is streamlining biologics manufacturing, reducing variability, and ensuring consistent product quality.

Continuous Bioprocessing Market Report Highlights:

  • Based on product, consumables & reagents dominated the market in 2024. The shift from traditional batch processing to continuous bioprocessing has led to a growing demand for continuous bioprocessing consumables& reagents
  • Based on application, the monoclonal antibodies segment dominated the market, with the largest revenue share of 29.98% in 2024. The shift toward biosimilars and regulatory support for process intensification further fuel adoption, as manufacturers seek to reduce production costs while maintaining high product purity and potency
  • Based on end use, pharmaceutical and biotechnology companies dominated the market, with the largest revenue share of 48.43% in 2024. The regulatory support from agencies like the FDA and EMA for continuous manufacturing and process intensification is further encouraging biopharma firms to invest in next-generation bioprocessing solutions
  • In 2024, North America led the market, accounting for the largest revenue share of 37.46%. This dominance is fueled by significant investments in biopharmaceutical R&D, a well-established manufacturing infrastructure, and favorable regulatory policies supporting advanced bioprocessing technologies.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. End Use
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Continuous bioprocessing market Variables and Trends

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
      • 3.2.1.1. Growing Demand for Biologics & Biosimilars
      • 3.2.1.2. Technological Advancements & Single-Use Systems
    • 3.2.2. Restraints
      • 3.2.2.1. High Initial Investment & Process Complexity
  • 3.3. Industry Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Continuous Bioprocessing: Product Estimates & Trend Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Continuous bioprocessing market: Product Movement Analysis
  • 4.3. Continuous bioprocessing market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Bioreactors
      • 4.4.2.1. Bioreactors market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Filtration Systems
      • 4.4.3.1. Filtration systems market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.4. Chromatography Systems
      • 4.4.4.1. Chromatography systems market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.5. Process Analytical Technologies
      • 4.4.5.1. Process analytical technologies market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.6. Others
      • 4.4.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Consumables & Reagents
    • 4.5.1. Consumables & reagents market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.2. Media & Buffers
      • 4.5.2.1. Media & buffers market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.3. Filters & Membranes
      • 4.5.3.1. Filters & membranes market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.4. Resin
      • 4.5.4.1. Resin market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.5. Tubing & Bags
      • 4.5.5.1. Tubing & bags market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.6. Other
      • 4.5.6.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Continuous Bioprocessing: Application Estimates & Trend Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Continuous bioprocessing market: Application Movement Analysis
  • 5.3. Continuous bioprocessing market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Monoclonal antibodies
    • 5.4.1. Monoclonal antibodies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Vaccines
    • 5.5.1. Vaccines market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Cell and gene therapy
    • 5.6.1. Cell and gene therapy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Research & Development
    • 5.7.1. Research & development market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.8. Other Applications
    • 5.8.1. Other applications market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Continuous Bioprocessing: End Use Estimates & Trend Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Continuous bioprocessing market: End Use Movement Analysis
  • 6.3. Continuous bioprocessing market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical and biotechnology companies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. CMOs and CROs
    • 6.5.1. CMOs and CROs market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Research and Academic Institutes
    • 6.6.1. Research and academic institutes market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Continuous Bioprocessing: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market Share Analysis, 2024 & 2030
  • 7.3. Continuous bioprocessing market by Region: Key Takeaways
  • 7.4. North America
    • 7.4.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Europe
    • 7.5.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.8. Norway
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.9. Denmark
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.7. South Korea
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.8. MEA
    • 7.8.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.8.3. South Africa
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Categorization
  • 8.2. Company Market Position Analysis, 2024
  • 8.3. Participant Overview
    • 8.3.1. Danaher
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. Sartorius AG
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Thermo Fisher Scientific Inc.
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. WuXi Biologics
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Ginkgo Bioworks
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Merck KGaA
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. GE Healthcare
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Repligen Corporation
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Asahi Kasei Bioprocess America, Inc.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 3 Global Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 4 Global Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 5 Global Continuous bioprocessing market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 7 North America Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 8 North America Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 9 North America Continuous bioprocessing market, by country, 2018 - 2030 (USD Million)
  • Table 10 U.S. Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 11 U.S. Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S. Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 14 Canada Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Mexico Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 17 Mexico Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 18 Mexico Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 20 Europe Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 21 Europe Continuous bioprocessing market, by country, 2018 - 2030 (USD Million)
  • Table 22 Europe Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Germany Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 24 Germany Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 25 Germany Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 26 UK Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 27 UK Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 28 UK Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 29 France Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 30 France Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 31 France Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 33 Italy Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 34 Italy Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 36 Spain Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Sweden Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 39 Sweden Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 40 Sweden Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Norway Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 42 Norway Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 43 Norway Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Denmark Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 45 Denmark Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 46 Denmark Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Continuous bioprocessing market, by country, 2018 - 2030 (USD Million)
  • Table 51 China Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 52 China Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 53 China Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Japan Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 55 Japan Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 56 Japan Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 57 India Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 58 India Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 59 India Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Australia Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 61 Australia Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 62 Australia Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 63 Thailand Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 64 Thailand Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 65 Thailand Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 66 South Korea Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 67 South Korea Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 68 South Korea Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Latin America Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 70 Latin America Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 71 Latin America Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 72 Latin America Continuous bioprocessing market, by country, 2018 - 2030 (USD Million)
  • Table 73 Brazil Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 74 Brazil Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 75 Brazil Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 77 Argentina Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 78 Argentina Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 79 Middle East and Africa Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 80 Middle East and Africa Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 81 Middle East and Africa Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 82 Middle East and Africa Continuous bioprocessing market, by country, 2018 - 2030 (USD Million)
  • Table 83 South Africa Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 84 South Africa Continuous bioprocessing market, by automation type, 2018 - 2030 (USD Million)
  • Table 85 South Africa Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 86 South Africa Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 90 UAE Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 91 UAE Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 92 UAE Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Continuous Bioprocessing: market outlook
  • Fig. 9 Continuous Bioprocessing competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Industry value chain analysis
  • Fig. 13 Continuous bioprocessing market driver impact
  • Fig. 14 Continuous bioprocessing market restraint impact
  • Fig. 15 Continuous bioprocessing market: Product movement analysis
  • Fig. 16 Continuous bioprocessing market: Product outlook and key takeaways
  • Fig. 17 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Bioreactors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Filtration systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Chromatography systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Process analytical technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Consumables & reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Media & buffers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Filters & membranes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Resin market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Tubing & Bags market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Continuous bioprocessing market: Application movement analysis
  • Fig. 30 Continuous bioprocessing market: Application outlook and key takeaways
  • Fig. 31 Monoclonal antibodies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Cell and gene therapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Research & Development market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Other Applications market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Continuous bioprocessing market: End use movement analysis
  • Fig. 37 Continuous bioprocessing market: End use outlook and key takeaways
  • Fig. 38 Pharmaceutical and biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 CMOs and CROs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Research and academic institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Global Continuous bioprocessing market: Regional movement analysis
  • Fig. 42 Global Continuous bioprocessing market: Regional outlook and key takeaways
  • Fig. 43 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)